207940
vs
REGN
207940
REGN
Over the past 12 months, Samsung Biologics Co Ltd has underperformed REGN, delivering a return of +0% compared to the REGN's +2% growth.
Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
Smart Verdict
AI-Powered
Let AI Decide.
207940
REGN